1. Peginterferon-α-2a (40kD) plus ribavirin: a new treatment option takes flight in chronic hepatitis C

   Drugs and Profile Reports 11 December 2012 Pages: 1 - 4

   

2. Dutasteride: profile report

   • J. Curtis Nickel
   • Gerald L. Andriole

   Drugs and Profile Reports 11 December 2012 Pages: 5 - 7

   

3. Controversy still abounds over the safest and most effective treatment of Graves’ disease in children

   Disease Management 11 December 2012 Pages: 7 - 10

   

4. Emollients and keratolytics remain the mainstay of therapy for patients with ichthyosis

   Disease Management 11 December 2012 Pages: 11 - 15

   

5. Zopiclone, zolpidem and zaleplon: get your ‘zzz’s’ without affecting performance the next day

   Disease Management 11 December 2012 Pages: 16 - 18

   

6. Cannabinoids courting attention because of their potential in CNS disorders

   Disease Management 11 December 2012 Pages: 19 - 22

   

7. First reports of adverse drug reactions (ADRs) in recent weeks

   Drug Reactions and Interactions 11 December 2012 Pages: 23 - 24

   

8. Racial differences in response to drug therapy for heart failure have implications in approaching patient treatment

   Practical Issues and Updates 11 December 2012 Pages: 25 - 26

   

9. New in the Marketplace

   Product Introductions 11 December 2012 Pages: 26 - 26